Event
Workshop on Improved Characterization of Mesenchymal Stem Cells for Clinical Trials
Wednesday, May 8, 2013
7:30 a.m.-12:00 p.m.
Southern Management Campus Center, Baltimore MD
Ann Anonsen
301-405-0285
aanonsen@umd.edu
http://www.pharmacy.umaryland.edu/centers/cersievents/msc/agenda.html
Multipotent mesenchymal stromal cell (MSC)-based cellular therapies hold great potential for the treatment of a wide array of medical conditions. However, MSCs are so novel that product characterization can be particularly challenging. For clinical use, current approaches to the characterization of human MSCs rely mostly on a few cell surface markers and qualitative, imprecise measures of cell activity. Optimal approaches to evaluation and selection of in-process or lot release tests that will predict the in vivo performance of cell-based therapies reliably remain unknown.
The Workshop on Improved Characterization of Mesenchymal Stem Cells for Clinical Trials will be held on Wednesday, May 8, 2013, in the Southern Management Corporation Campus Center at the University of Maryland, Baltimore, located at 621 West Lombard Street in Baltimore, MD. The goal of this workshop is to assess MSC characterization and discuss methods that can be used to predict the quality, potency, and safety of MSCs, with implications for other types of stem cells and cell-based products. This workshop is co-sponsored by the University of Maryland Center for Excellence in Regulatory Science and Innovation (M-CERSI) and the Food and Drug Administration (FDA).
